Abstract
Sodium fluoride F-18 (NaF) is a positron-emitting radiotracer used in imaging patients with suspected bone metastases. NaF PET/MRI provides numerous advantages over the conventional technetium bone scans, most importantly higher sensitivity and specificity, greater spatial resolution, and significantly shorter uptake and scan times.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Bastawrous S, Bhargava P, Behnia F, Djang DS, Haseley DR. Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice. Radiographics. 2014;34(5):1295–316.
Cook GJ, Azad G, Padhani AR. Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiology. Clin Transl Imaging. 2016;4(6):439–47.
Li Y, Schiepers C, Lake R, Dadparvar S, Berenji GR. Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases. Bone. 2012;50(1):128–39.
Mosavi F, Johansson S, Sandberg DT, Turesson I, Sörensen J, Ahlström H. Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma. AJR Am J Roentgenol. 2012;199(5):1114–20.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Franceschi, A.M., Matthews, R. (2018). Prostate Cancer with F-18 Sodium Fluoride. In: PET/MR Imaging . Springer, Cham. https://doi.org/10.1007/978-3-319-65106-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-65106-4_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65105-7
Online ISBN: 978-3-319-65106-4
eBook Packages: MedicineMedicine (R0)